S'abonner

Subclinical and Overt Newborn Opioid Exposure: Prevalence and First-Year Healthcare Utilization - 27/01/21

Doi : 10.1016/j.jpeds.2020.03.052 
Zana Percy, BS 1, 2, Cole Brokamp, PhD 3, 4, Jennifer M. McAllister, MD 3, 5, Patrick Ryan, PhD 2, 3, 4, Scott L. Wexelblatt, MD 3, 5, Eric S. Hall, PhD 3, 5, 6,
1 Medical Scientist Training Program, University of Cincinnati College of Medicine, Cincinnati, OH 
2 Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH 
3 Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 
4 Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 
5 Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 
6 Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 

Reprint requests: Eric S. Hall, PhD, 3333 Burnet Avenue, Cincinnati, OH 452293333 Burnet AvenueCincinnatiOH45229

Abstract

Objectives

To categorize newborn infants in Hamilton County, Ohio by late pregnancy fetal opioid exposure status and to assess their first-year healthcare utilization.

Study design

We used a population-based cohort of 41 136 live births from 2014-2017 and analyzed healthcare encounters in the first year of life from electronic health records. We prospectively assessed for the presence of opioids in maternal urine collected at delivery and for a diagnosis of newborn neonatal abstinence syndrome (NAS). At birth, infants were classified as unexposed to opioids, exposed to opioids and diagnosed with NAS, or subclinically exposed to opioids (exposure that did not result in NAS).

Results

The prevalence of newborn opioid exposure was 37 per 1000 births. The duration of the hospital birth encounter was significantly longer for infants with subclinical exposure compared with unexposed infants (10% increase; 95% CI, 7%-13%). However, duration for infants with subclinical exposure was shorter compared to those with NAS. Neither subclinical exposure nor NAS was associated with total emergency department visits. Subclinical exposure was associated with increased odds of having at least 1 hospitalization in the first year. However, the total length of stay for hospitalizations was 82% that of the unexposed group (95% CI, 75%-89%). Infants with NAS had a 213% longer total length of stay compared with the unexposed group (95% CI, 191%-237%).

Conclusions

Subclinical and overt opioid exposure among newborn infants was associated with increased first-year healthcare utilization. From 2014 to 2017, this cost the Hamilton County healthcare system an estimated $1 109 452 for longer birth encounters alone.

Le texte complet de cet article est disponible en PDF.

Keywords : pregnancy, cohort, substance abuse

Abbreviations : CCHMC, DAG, ED, ICD, NAS, SES, ZIP


Plan


 The patient cohort was obtained from the Cincinnati regional Maternal and Infant Data Hub, supported by the National Center for Advancing Translational Sciences of the National Institutes of Health through the Center for Clinical and Translational Science and Training at the University of Cincinnati (5UL1TR001425-02). This work was also supported by a University of Cincinnati Medical Scientist Training Program Grant supported by the National Institutes of Health (2T32GM063483-1). The authors declare no conflicts of interest.


© 2020  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 222

P. 52 - juillet 2020 Retour au numéro
Article précédent Article précédent
  • Prenatal Maternal Objective and Subjective Stress Exposures and Rapid Infant Weight Gain
  • Jennifer N. Felder, Elissa Epel, Michael Coccia, Alana Cordeiro, Barbara Laraia, Nancy Adler, Kimberly Coleman-Phox, Nicole R. Bush
| Article suivant Article suivant
  • Probiotic Use and Safety in the Neonatal Intensive Care Unit: A Matched Cohort Study
  • Keyaria D. Gray, Julia A. Messina, Christopher Cortina, Tanasha Owens, Madeline Fowler, Matthew Foster, Simi Gbadegesin, Reese H. Clark, Daniel K. Benjamin, Kanecia O. Zimmerman, Rachel G. Greenberg

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.